Levothyroxine Sodium Tablet
Product Images NDC 51655-479

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (449d2ef9 3580 46c8 8fe5 5d81cb18e40f 01)

Chemical structure of Levothyroxine Sodium showing its molecular arrangement including iodine atoms, amino group, and sodium ion as part of the compound.*

FDA Label Image

Label 2 (51655 479 52 Master Bottle Label Approval Rev A 02 21)

Label for Levothyroxine Sodium Tablets, USP 150 mcg (0.15 mg) oral tablets by Northwind Health Company, LLC. The package contains 30 tablets. The label includes storage instructions, dosage note to see package insert, and product batch details with NDC 51655-479-52.*

FDA Label Image

Label 2 (51655 528 52 Master Bottle Label Approval Rev A 01 21)

Label for Levothyroxine Sodium Tablets, USP 175 mcg (0.175 mg), 30 tablets, oral dosage form. The label includes storage instructions, dosage note to see package insert, and manufacturer information for Northwind Pharmaceuticals, Inc. It is marked Rx Only and includes an NDC number 51655-528-52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.